# Serum Intercellular Adhesion Molecule -1 in Acne Vulgaris Patients : Effect of Montelukast

> **NCT06340984** · PHASE3 · UNKNOWN · sponsor: **South Valley University** · enrollment: 60 (estimated)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Montelukast 10 Mg Oral Tablet

## Key facts

- **NCT ID:** NCT06340984
- **Lead sponsor:** South Valley University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-06
- **Primary completion:** 2024-11
- **Final completion:** 2025-02
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06340984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06340984, "Serum Intercellular Adhesion Molecule -1 in Acne Vulgaris Patients : Effect of Montelukast". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06340984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*